116 related articles for article (PubMed ID: 8289467)
1. Interleukin-4 (IL-4) inhibits proliferation and spontaneous cytokine release by chronic lymphocytic leukaemia cells.
Reittie JE; Hoffbrand AV
Leuk Res; 1994 Jan; 18(1):55-60. PubMed ID: 8289467
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia.
Reittie JE; Yong KL; Panayiotidis P; Hoffbrand AV
Leuk Lymphoma; 1996 Jun; 22(1-2):83-90, follow. 186, color plate VI. PubMed ID: 8724532
[TBL] [Abstract][Full Text] [Related]
3. Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta.
Moberts R; Hoogerbrugge H; van Agthoven T; Löwenberg B; Touw I
Leuk Res; 1989; 13(11):973-80. PubMed ID: 2481793
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta.
Aderka D; Maor Y; Novick D; Engelmann H; Kahn Y; Levo Y; Wallach D; Revel M
Blood; 1993 Apr; 81(8):2076-84. PubMed ID: 8386026
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-4 inhibits both paracrine and autocrine tumor necrosis factor-alpha-induced proliferation of B chronic lymphocytic leukemia cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Blood; 1992 Sep; 80(5):1299-306. PubMed ID: 1381243
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.
Larsson LG; Carlsson M; Schena M; Lantz M; Caligaris-Cappio F; Nilsson K
Leukemia; 1993 Feb; 7(2):226-34. PubMed ID: 8381194
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative effect of interleukin-4 in B chronic lymphocytic leukemia.
Luo HY; Rubio M; Biron G; Delespesse G; Sarfati M
J Immunother (1991); 1991 Dec; 10(6):418-25. PubMed ID: 1768675
[TBL] [Abstract][Full Text] [Related]
8. Effect of IL-4 and IL-6 on the proliferation and differentiation of B-chronic lymphocytic leukemia cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Leukemia; 1993 Apr; 7(4):618-24. PubMed ID: 8464239
[TBL] [Abstract][Full Text] [Related]
9. IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro.
Brass U; Tretter T; Schneller F; Schuler M; Huber C; Peschel C
J Interferon Cytokine Res; 1999 Apr; 19(4):335-43. PubMed ID: 10334384
[TBL] [Abstract][Full Text] [Related]
10. Effect of interleukins on the proliferation and survival of B cell chronic lymphocytic leukaemia cells.
Mainou-Fowler T; Copplestone JA; Prentice AG
J Clin Pathol; 1995 May; 48(5):482-7. PubMed ID: 7629299
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A inhibits cytokine-induced proliferation in B-chronic lymphocytic leukemia.
Schmid M; Merk B; Porzsolt F
Leuk Lymphoma; 1994 Oct; 15(3-4):317-25. PubMed ID: 7866281
[TBL] [Abstract][Full Text] [Related]
12. Release of interleukin-6 in cultured B-chronic lymphocytic leukaemia cells is associated with both activation and cell death via apoptosis.
Büssing A; Stein GM; Stumpf C; Schietzel M
Anticancer Res; 1999; 19(5B):3953-9. PubMed ID: 10628337
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis.
Chaouchi N; Wallon C; Goujard C; Tertian G; Rudent A; Caput D; Ferrera P; Minty A; Vazquez A; Delfraissy JF
Blood; 1996 Feb; 87(3):1022-9. PubMed ID: 8562926
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro.
Panayiotidis P; Ganeshaguru K; Jabbar SA; Hoffbrand AV
Br J Haematol; 1993 Nov; 85(3):439-45. PubMed ID: 8136263
[TBL] [Abstract][Full Text] [Related]
15. Molecular investigation of the cytokines produced by normal and malignant B lymphocytes.
Schena M; Gaidano G; Gottardi D; Malavasi F; Larsson LG; Nilsson K; Caligaris-Cappio F
Leukemia; 1992 Feb; 6(2):120-5. PubMed ID: 1372670
[TBL] [Abstract][Full Text] [Related]
16. Diminished production of interleukin-6 in chronic lymphocytic leukaemia (B-CLL) cells from patients at advanced stages of disease. Tampere CLL Group.
Hulkkonen J; Vilpo J; Vilpo L; Hurme M
Br J Haematol; 1998 Mar; 100(3):478-83. PubMed ID: 9504629
[TBL] [Abstract][Full Text] [Related]
17. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
[TBL] [Abstract][Full Text] [Related]
18. Verapamil inhibits B-cell proliferation and tumor necrosis factor release and induces a clinical response in B-cell chronic lymphocytic leukemia.
Berrebi A; Shtalrid M; Klepfish A; Bassous L; Kushnir M; Shulman L; Vorst E; Hahn T
Leukemia; 1994 Dec; 8(12):2214-6. PubMed ID: 7808009
[TBL] [Abstract][Full Text] [Related]
19. Effect of interleukin-1, tumor necrosis factor-alpha, and interferon-alpha on the blast cells of acute myeloblastic leukemia.
Carter A; Silvian-Draxler I; Tatarsky I
Am J Hematol; 1992 Aug; 40(4):245-51. PubMed ID: 1503080
[TBL] [Abstract][Full Text] [Related]
20. Heterogenous response of B lymphocytes to transforming growth factor-beta in B-cell chronic lymphocytic leukaemia: correlation with the expression of TGF-beta receptors.
Lagneaux L; Delforge A; Bron D; Massy M; Bernier M; Stryckmans P
Br J Haematol; 1997 Jun; 97(3):612-20. PubMed ID: 9207409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
